A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

NCT05838755 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

147

Enrollment

INDUSTRY

Sponsor class

Stopped The study met futility criteria at pre-planned interim analysis, showing no clinical efficacy of the investigational drug. Based on the lack of efficacy at the interim data review, the sponsor decided to terminate the study.

Conditions

Pain

Interventions

DRUG: GSK3858279
DRUG: Placebo

Sponsor

GlaxoSmithKline